nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—ABCB1—lung cancer	0.232	1	CbGaD
Epinastine—ABCB1—Topotecan—lung cancer	0.0349	0.0605	CbGbCtD
Epinastine—CYP2B6—Irinotecan—lung cancer	0.0332	0.0577	CbGbCtD
Epinastine—ABCB1—Gefitinib—lung cancer	0.0319	0.0554	CbGbCtD
Epinastine—CYP2D6—Gefitinib—lung cancer	0.0301	0.0522	CbGbCtD
Epinastine—CYP2B6—Cisplatin—lung cancer	0.0271	0.047	CbGbCtD
Epinastine—ABCB1—Vinorelbine—lung cancer	0.0246	0.0426	CbGbCtD
Epinastine—CYP2D6—Vinorelbine—lung cancer	0.0232	0.0402	CbGbCtD
Epinastine—CYP3A4—Topotecan—lung cancer	0.0209	0.0363	CbGbCtD
Epinastine—ABCB1—Crizotinib—lung cancer	0.0196	0.0339	CbGbCtD
Epinastine—CYP3A4—Gefitinib—lung cancer	0.0191	0.0332	CbGbCtD
Epinastine—ABCB1—Gemcitabine—lung cancer	0.0191	0.0332	CbGbCtD
Epinastine—ABCB1—Erlotinib—lung cancer	0.0189	0.0327	CbGbCtD
Epinastine—CYP3A4—Teniposide—lung cancer	0.0185	0.0322	CbGbCtD
Epinastine—CYP2B6—Doxorubicin—lung cancer	0.0182	0.0315	CbGbCtD
Epinastine—CYP2D6—Erlotinib—lung cancer	0.0178	0.0308	CbGbCtD
Epinastine—ABCB1—Paclitaxel—lung cancer	0.0173	0.03	CbGbCtD
Epinastine—ABCB1—Irinotecan—lung cancer	0.017	0.0296	CbGbCtD
Epinastine—ABCB1—Vinblastine—lung cancer	0.0152	0.0263	CbGbCtD
Epinastine—CYP3A4—Vinorelbine—lung cancer	0.0147	0.0255	CbGbCtD
Epinastine—CYP2D6—Vinblastine—lung cancer	0.0143	0.0248	CbGbCtD
Epinastine—ABCB1—Cisplatin—lung cancer	0.0139	0.0241	CbGbCtD
Epinastine—ABCB1—Etoposide—lung cancer	0.0136	0.0237	CbGbCtD
Epinastine—HTR2A—phrenic nerve—lung cancer	0.013	0.275	CbGeAlD
Epinastine—ABCB1—Docetaxel—lung cancer	0.0125	0.0217	CbGbCtD
Epinastine—CYP3A4—Crizotinib—lung cancer	0.0117	0.0203	CbGbCtD
Epinastine—CYP3A4—Erlotinib—lung cancer	0.0113	0.0196	CbGbCtD
Epinastine—CYP3A4—Paclitaxel—lung cancer	0.0103	0.018	CbGbCtD
Epinastine—CYP3A4—Irinotecan—lung cancer	0.0102	0.0177	CbGbCtD
Epinastine—ABCB1—Doxorubicin—lung cancer	0.00931	0.0161	CbGbCtD
Epinastine—CYP3A4—Vinblastine—lung cancer	0.00908	0.0157	CbGbCtD
Epinastine—ABCB1—Methotrexate—lung cancer	0.00902	0.0156	CbGbCtD
Epinastine—CYP2D6—Doxorubicin—lung cancer	0.00877	0.0152	CbGbCtD
Epinastine—CYP3A4—Etoposide—lung cancer	0.00818	0.0142	CbGbCtD
Epinastine—HTR7—pulmonary artery—lung cancer	0.00756	0.16	CbGeAlD
Epinastine—CYP3A4—Docetaxel—lung cancer	0.00748	0.013	CbGbCtD
Epinastine—CYP3A4—Doxorubicin—lung cancer	0.00558	0.00967	CbGbCtD
Epinastine—HTR2A—pulmonary artery—lung cancer	0.00471	0.0997	CbGeAlD
Epinastine—Lacrimation increased—Pemetrexed—lung cancer	0.00249	0.0647	CcSEcCtD
Epinastine—HRH2—cardiac atrium—lung cancer	0.00174	0.0367	CbGeAlD
Epinastine—Upper respiratory tract infection—Crizotinib—lung cancer	0.00147	0.0381	CcSEcCtD
Epinastine—HRH2—lung—lung cancer	0.00133	0.0281	CbGeAlD
Epinastine—HTR7—respiratory system—lung cancer	0.00127	0.0269	CbGeAlD
Epinastine—Pharyngitis—Pemetrexed—lung cancer	0.00115	0.0297	CcSEcCtD
Epinastine—Cough increased—Irinotecan—lung cancer	0.00106	0.0276	CcSEcCtD
Epinastine—HTR7—epithelium—lung cancer	0.00106	0.0225	CbGeAlD
Epinastine—Lacrimation increased—Irinotecan—lung cancer	0.00106	0.0274	CcSEcCtD
Epinastine—ADRA1A—epithelium—lung cancer	0.00102	0.0217	CbGeAlD
Epinastine—CYP2B6—respiratory system—lung cancer	0.000972	0.0206	CbGeAlD
Epinastine—HRH1—respiratory system—lung cancer	0.000949	0.0201	CbGeAlD
Epinastine—HTR7—trachea—lung cancer	0.000939	0.0199	CbGeAlD
Epinastine—Eye irritation—Paclitaxel—lung cancer	0.00093	0.0241	CcSEcCtD
Epinastine—HRH2—lymph node—lung cancer	0.000908	0.0192	CbGeAlD
Epinastine—Infection—Crizotinib—lung cancer	0.000892	0.0231	CcSEcCtD
Epinastine—Cough—Gefitinib—lung cancer	0.000871	0.0226	CcSEcCtD
Epinastine—Lacrimation increased—Paclitaxel—lung cancer	0.000862	0.0224	CcSEcCtD
Epinastine—Infection—Pemetrexed—lung cancer	0.000815	0.0211	CcSEcCtD
Epinastine—Infection—Gefitinib—lung cancer	0.00081	0.021	CcSEcCtD
Epinastine—CYP2B6—bronchus—lung cancer	0.0008	0.0169	CbGeAlD
Epinastine—HRH1—epithelium—lung cancer	0.000793	0.0168	CbGeAlD
Epinastine—HTR2A—respiratory system—lung cancer	0.000793	0.0168	CbGeAlD
Epinastine—Eye irritation—Docetaxel—lung cancer	0.000788	0.0205	CcSEcCtD
Epinastine—ADRA2A—bronchus—lung cancer	0.000767	0.0162	CbGeAlD
Epinastine—Lacrimation increased—Docetaxel—lung cancer	0.00073	0.019	CcSEcCtD
Epinastine—Pharyngitis—Vinblastine—lung cancer	0.000708	0.0184	CcSEcCtD
Epinastine—HRH1—trachea—lung cancer	0.000701	0.0148	CbGeAlD
Epinastine—Rhinitis—Topotecan—lung cancer	0.000695	0.018	CcSEcCtD
Epinastine—ADRA2A—trachea—lung cancer	0.000689	0.0146	CbGeAlD
Epinastine—Pharyngitis—Topotecan—lung cancer	0.000688	0.0179	CcSEcCtD
Epinastine—HTR7—lung—lung cancer	0.000675	0.0143	CbGeAlD
Epinastine—HTR2A—epithelium—lung cancer	0.000662	0.014	CbGeAlD
Epinastine—Infection—Teniposide—lung cancer	0.00066	0.0171	CcSEcCtD
Epinastine—ADRA2A—cardiac atrium—lung cancer	0.000647	0.0137	CbGeAlD
Epinastine—HTR2A—trachea—lung cancer	0.000586	0.0124	CbGeAlD
Epinastine—Pruritus—Pemetrexed—lung cancer	0.00058	0.0151	CcSEcCtD
Epinastine—Pruritus—Gefitinib—lung cancer	0.000577	0.015	CcSEcCtD
Epinastine—Nasopharyngitis—Cisplatin—lung cancer	0.000574	0.0149	CcSEcCtD
Epinastine—Upper respiratory tract infection—Irinotecan—lung cancer	0.000568	0.0147	CcSEcCtD
Epinastine—Cough—Topotecan—lung cancer	0.000527	0.0137	CcSEcCtD
Epinastine—Cough—Erlotinib—lung cancer	0.000521	0.0135	CcSEcCtD
Epinastine—ABCB1—respiratory system—lung cancer	0.000519	0.011	CbGeAlD
Epinastine—CYP2B6—lung—lung cancer	0.000516	0.0109	CbGeAlD
Epinastine—Nasopharyngitis—Paclitaxel—lung cancer	0.000516	0.0134	CcSEcCtD
Epinastine—HRH1—lung—lung cancer	0.000504	0.0107	CbGeAlD
Epinastine—ADRA2A—lung—lung cancer	0.000495	0.0105	CbGeAlD
Epinastine—Rhinitis—Irinotecan—lung cancer	0.00049	0.0127	CcSEcCtD
Epinastine—Infection—Topotecan—lung cancer	0.000489	0.0127	CcSEcCtD
Epinastine—Infection—Erlotinib—lung cancer	0.000484	0.0126	CcSEcCtD
Epinastine—Rhinitis—Gemcitabine—lung cancer	0.000478	0.0124	CcSEcCtD
Epinastine—Pharyngitis—Gemcitabine—lung cancer	0.000473	0.0123	CcSEcCtD
Epinastine—Pruritus—Teniposide—lung cancer	0.00047	0.0122	CcSEcCtD
Epinastine—Upper respiratory tract infection—Paclitaxel—lung cancer	0.000463	0.012	CcSEcCtD
Epinastine—Cough increased—Doxorubicin—lung cancer	0.000459	0.0119	CcSEcCtD
Epinastine—Lacrimation increased—Doxorubicin—lung cancer	0.000456	0.0118	CcSEcCtD
Epinastine—Cough—Vinorelbine—lung cancer	0.00045	0.0117	CcSEcCtD
Epinastine—Nasopharyngitis—Docetaxel—lung cancer	0.000437	0.0113	CcSEcCtD
Epinastine—ABCB1—epithelium—lung cancer	0.000434	0.00918	CbGeAlD
Epinastine—HTR2A—lung—lung cancer	0.000421	0.0089	CbGeAlD
Epinastine—Infection—Vinorelbine—lung cancer	0.000418	0.0109	CcSEcCtD
Epinastine—Sinusitis—Paclitaxel—lung cancer	0.000417	0.0108	CcSEcCtD
Epinastine—Headache—Teniposide—lung cancer	0.000416	0.0108	CcSEcCtD
Epinastine—Rhinitis—Paclitaxel—lung cancer	0.0004	0.0104	CcSEcCtD
Epinastine—Pharyngitis—Paclitaxel—lung cancer	0.000396	0.0103	CcSEcCtD
Epinastine—ABCB1—trachea—lung cancer	0.000384	0.00812	CbGeAlD
Epinastine—Cough—Irinotecan—lung cancer	0.000371	0.00964	CcSEcCtD
Epinastine—Cough—Gemcitabine—lung cancer	0.000362	0.00939	CcSEcCtD
Epinastine—Pruritus—Topotecan—lung cancer	0.000348	0.00904	CcSEcCtD
Epinastine—Infection—Irinotecan—lung cancer	0.000345	0.00896	CcSEcCtD
Epinastine—Pruritus—Erlotinib—lung cancer	0.000345	0.00895	CcSEcCtD
Epinastine—HRH1—lymph node—lung cancer	0.000345	0.00729	CbGeAlD
Epinastine—Rhinitis—Docetaxel—lung cancer	0.000339	0.0088	CcSEcCtD
Epinastine—ADRA2A—lymph node—lung cancer	0.000338	0.00716	CbGeAlD
Epinastine—Infection—Gemcitabine—lung cancer	0.000336	0.00873	CcSEcCtD
Epinastine—Pharyngitis—Docetaxel—lung cancer	0.000336	0.00871	CcSEcCtD
Epinastine—Headache—Vinblastine—lung cancer	0.000318	0.00824	CcSEcCtD
Epinastine—Infection—Cisplatin—lung cancer	0.000313	0.00813	CcSEcCtD
Epinastine—Cough—Etoposide—lung cancer	0.000309	0.00802	CcSEcCtD
Epinastine—Headache—Topotecan—lung cancer	0.000308	0.00801	CcSEcCtD
Epinastine—Headache—Erlotinib—lung cancer	0.000305	0.00792	CcSEcCtD
Epinastine—ABCB1—bone marrow—lung cancer	0.000304	0.00644	CbGeAlD
Epinastine—Cough—Paclitaxel—lung cancer	0.000303	0.00786	CcSEcCtD
Epinastine—Pruritus—Vinorelbine—lung cancer	0.000298	0.00773	CcSEcCtD
Epinastine—Infection—Etoposide—lung cancer	0.000287	0.00745	CcSEcCtD
Epinastine—Upper respiratory tract infection—Methotrexate—lung cancer	0.000283	0.00734	CcSEcCtD
Epinastine—Infection—Paclitaxel—lung cancer	0.000281	0.00731	CcSEcCtD
Epinastine—ABCB1—lung—lung cancer	0.000276	0.00583	CbGeAlD
Epinastine—Desipramine—CYP2A6—lung cancer	0.000273	0.135	CrCbGaD
Epinastine—Nasopharyngitis—Doxorubicin—lung cancer	0.000273	0.00708	CcSEcCtD
Epinastine—Headache—Vinorelbine—lung cancer	0.000264	0.00685	CcSEcCtD
Epinastine—Cough—Docetaxel—lung cancer	0.000257	0.00666	CcSEcCtD
Epinastine—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000245	0.00636	CcSEcCtD
Epinastine—Pharyngitis—Methotrexate—lung cancer	0.000242	0.00628	CcSEcCtD
Epinastine—Pruritus—Gemcitabine—lung cancer	0.000239	0.00621	CcSEcCtD
Epinastine—Infection—Docetaxel—lung cancer	0.000239	0.00619	CcSEcCtD
Epinastine—Nortriptyline—CYP2E1—lung cancer	0.000236	0.117	CrCbGaD
Epinastine—Oxcarbazepine—ALB—lung cancer	0.000231	0.114	CrCbGaD
Epinastine—Sinusitis—Doxorubicin—lung cancer	0.00022	0.00572	CcSEcCtD
Epinastine—Headache—Irinotecan—lung cancer	0.000218	0.00565	CcSEcCtD
Epinastine—Headache—Gemcitabine—lung cancer	0.000212	0.0055	CcSEcCtD
Epinastine—Rhinitis—Doxorubicin—lung cancer	0.000212	0.00549	CcSEcCtD
Epinastine—Pharyngitis—Doxorubicin—lung cancer	0.000209	0.00543	CcSEcCtD
Epinastine—Pruritus—Etoposide—lung cancer	0.000204	0.00531	CcSEcCtD
Epinastine—Pruritus—Paclitaxel—lung cancer	0.0002	0.0052	CcSEcCtD
Epinastine—Desipramine—CYP2E1—lung cancer	0.000194	0.096	CrCbGaD
Epinastine—ABCB1—lymph node—lung cancer	0.000189	0.00399	CbGeAlD
Epinastine—Cough—Methotrexate—lung cancer	0.000185	0.0048	CcSEcCtD
Epinastine—Headache—Etoposide—lung cancer	0.000181	0.0047	CcSEcCtD
Epinastine—Headache—Paclitaxel—lung cancer	0.000178	0.00461	CcSEcCtD
Epinastine—Infection—Methotrexate—lung cancer	0.000172	0.00446	CcSEcCtD
Epinastine—Pruritus—Docetaxel—lung cancer	0.00017	0.00441	CcSEcCtD
Epinastine—Imipramine—CYP2E1—lung cancer	0.000165	0.0814	CrCbGaD
Epinastine—Amitriptyline—CYP2E1—lung cancer	0.000164	0.0809	CrCbGaD
Epinastine—Cough—Doxorubicin—lung cancer	0.00016	0.00416	CcSEcCtD
Epinastine—Headache—Docetaxel—lung cancer	0.00015	0.0039	CcSEcCtD
Epinastine—Carbamazepine—ABCB1—lung cancer	0.00015	0.0742	CrCbGaD
Epinastine—Infection—Doxorubicin—lung cancer	0.000149	0.00386	CcSEcCtD
Epinastine—Nortriptyline—ALB—lung cancer	0.00013	0.0641	CrCbGaD
Epinastine—Pruritus—Methotrexate—lung cancer	0.000122	0.00318	CcSEcCtD
Epinastine—Trimipramine—ABCB1—lung cancer	0.000116	0.0576	CrCbGaD
Epinastine—Headache—Methotrexate—lung cancer	0.000108	0.00281	CcSEcCtD
Epinastine—Pruritus—Doxorubicin—lung cancer	0.000106	0.00275	CcSEcCtD
Epinastine—Desipramine—ABCB1—lung cancer	0.000102	0.0503	CrCbGaD
Epinastine—Headache—Doxorubicin—lung cancer	9.39e-05	0.00244	CcSEcCtD
Epinastine—Amitriptyline—ALB—lung cancer	8.99e-05	0.0445	CrCbGaD
Epinastine—Imipramine—ABCB1—lung cancer	8.63e-05	0.0427	CrCbGaD
Epinastine—Amitriptyline—ABCB1—lung cancer	8.58e-05	0.0424	CrCbGaD
Epinastine—CYP2B6—Metabolism—CREBBP—lung cancer	7.31e-06	7.03e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—ALB—lung cancer	7.3e-06	7.02e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—BRAF—lung cancer	7.27e-06	6.99e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—BRAF—lung cancer	7.25e-06	6.97e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	7.25e-06	6.97e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—VEGFA—lung cancer	7.23e-06	6.94e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—POMC—lung cancer	7.21e-06	6.93e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6R—lung cancer	7.18e-06	6.9e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CREBBP—lung cancer	7.17e-06	6.89e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6R—lung cancer	7.17e-06	6.89e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CREBBP—lung cancer	7.16e-06	6.88e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—STAT3—lung cancer	7.15e-06	6.87e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—NRAS—lung cancer	7.14e-06	6.86e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TP53—lung cancer	7.13e-06	6.85e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—BRAF—lung cancer	7.12e-06	6.84e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ENO1—lung cancer	7.1e-06	6.83e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—EGFR—lung cancer	7.05e-06	6.77e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—APC—lung cancer	7.04e-06	6.76e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	7.04e-06	6.76e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—KIT—lung cancer	7.04e-06	6.76e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—NRAS—lung cancer	7.04e-06	6.76e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6R—lung cancer	7.03e-06	6.76e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—EGFR—lung cancer	7.03e-06	6.76e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CREBBP—lung cancer	7.02e-06	6.75e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CYP1A1—lung cancer	7e-06	6.73e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGF—lung cancer	6.96e-06	6.68e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ERCC2—lung cancer	6.94e-06	6.67e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CD—lung cancer	6.94e-06	6.66e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—EGFR—lung cancer	6.9e-06	6.63e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ALB—lung cancer	6.85e-06	6.58e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAP2K1—lung cancer	6.84e-06	6.58e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MAPK3—lung cancer	6.83e-06	6.57e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAP2K1—lung cancer	6.83e-06	6.56e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—HRAS—lung cancer	6.81e-06	6.55e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CD—lung cancer	6.8e-06	6.53e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CD—lung cancer	6.78e-06	6.52e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	6.74e-06	6.48e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	6.73e-06	6.47e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	6.72e-06	6.46e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	6.7e-06	6.44e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—POMC—lung cancer	6.7e-06	6.44e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	6.66e-06	6.4e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—KRAS—lung cancer	6.66e-06	6.4e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MYC—lung cancer	6.65e-06	6.39e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—KRAS—lung cancer	6.64e-06	6.38e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—BRAF—lung cancer	6.61e-06	6.36e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	6.59e-06	6.34e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6R—lung cancer	6.53e-06	6.28e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CREBBP—lung cancer	6.52e-06	6.27e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL6—lung cancer	6.52e-06	6.27e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—KRAS—lung cancer	6.52e-06	6.26e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EGFR—lung cancer	6.5e-06	6.25e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CB—lung cancer	6.45e-06	6.2e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—EGFR—lung cancer	6.41e-06	6.16e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTGS2—lung cancer	6.39e-06	6.14e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—APOA1—lung cancer	6.37e-06	6.12e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP2E1—lung cancer	6.37e-06	6.12e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NQO1—lung cancer	6.3e-06	6.05e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	6.23e-06	5.98e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	6.19e-06	5.94e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—KRAS—lung cancer	6.14e-06	5.9e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	6.13e-06	5.89e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	6.12e-06	5.88e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	6.1e-06	5.86e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MDM2—lung cancer	6.09e-06	5.85e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MDM2—lung cancer	6.08e-06	5.84e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—RAF1—lung cancer	6.07e-06	5.83e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—RAF1—lung cancer	6.06e-06	5.82e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—KRAS—lung cancer	6.06e-06	5.82e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CB—lung cancer	6.05e-06	5.81e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—AKT1—lung cancer	6.02e-06	5.78e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—APOA1—lung cancer	6.01e-06	5.77e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—ERBB2—lung cancer	6.01e-06	5.77e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—ERBB2—lung cancer	5.99e-06	5.76e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTGS2—lung cancer	5.99e-06	5.76e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	5.99e-06	5.75e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MDM2—lung cancer	5.96e-06	5.73e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—RAF1—lung cancer	5.94e-06	5.71e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MTOR—lung cancer	5.93e-06	5.69e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CB—lung cancer	5.93e-06	5.69e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MTOR—lung cancer	5.91e-06	5.68e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CB—lung cancer	5.91e-06	5.68e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—ERBB2—lung cancer	5.88e-06	5.65e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CG—lung cancer	5.82e-06	5.59e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	5.8e-06	5.58e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MTOR—lung cancer	5.8e-06	5.58e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CXCL8—lung cancer	5.7e-06	5.47e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CXCL8—lung cancer	5.68e-06	5.46e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—STK11—lung cancer	5.68e-06	5.46e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—HRAS—lung cancer	5.66e-06	5.44e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—HRAS—lung cancer	5.65e-06	5.43e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—PIK3CA—lung cancer	5.64e-06	5.42e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	5.58e-06	5.36e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTEN—lung cancer	5.57e-06	5.35e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	5.56e-06	5.35e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MDM2—lung cancer	5.54e-06	5.32e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	5.54e-06	5.32e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—POMC—lung cancer	5.54e-06	5.32e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—RAF1—lung cancer	5.52e-06	5.31e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—AKT1—lung cancer	5.5e-06	5.29e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—AKT1—lung cancer	5.49e-06	5.27e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CG—lung cancer	5.48e-06	5.27e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—ERBB2—lung cancer	5.46e-06	5.25e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TP53—lung cancer	5.46e-06	5.25e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CASP3—lung cancer	5.45e-06	5.24e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL2—lung cancer	5.44e-06	5.23e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CASP3—lung cancer	5.44e-06	5.23e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL2—lung cancer	5.43e-06	5.22e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL6—lung cancer	5.42e-06	5.2e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL6—lung cancer	5.4e-06	5.19e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CREBBP—lung cancer	5.4e-06	5.18e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MTOR—lung cancer	5.39e-06	5.18e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	5.39e-06	5.18e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	5.39e-06	5.18e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CASP3—lung cancer	5.34e-06	5.13e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL2—lung cancer	5.33e-06	5.12e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—EP300—lung cancer	5.31e-06	5.11e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCND1—lung cancer	5.31e-06	5.1e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL6—lung cancer	5.3e-06	5.1e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—JUN—lung cancer	5.29e-06	5.09e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCND1—lung cancer	5.29e-06	5.09e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—JUN—lung cancer	5.28e-06	5.08e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTP1—lung cancer	5.25e-06	5.05e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTEN—lung cancer	5.22e-06	5.02e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—HRAS—lung cancer	5.22e-06	5.02e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—POMC—lung cancer	5.22e-06	5.02e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCND1—lung cancer	5.2e-06	4.99e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—JUN—lung cancer	5.18e-06	4.98e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	5.18e-06	4.98e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MMP9—lung cancer	5.15e-06	4.95e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	5.15e-06	4.95e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MMP9—lung cancer	5.14e-06	4.94e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	5.13e-06	4.93e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CDKN1A—lung cancer	5.12e-06	4.92e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PTEN—lung cancer	5.12e-06	4.92e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CD—lung cancer	5.12e-06	4.92e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CAT—lung cancer	5.11e-06	4.91e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PTEN—lung cancer	5.11e-06	4.91e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CREBBP—lung cancer	5.08e-06	4.89e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ALB—lung cancer	5.05e-06	4.85e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MMP9—lung cancer	5.04e-06	4.85e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	5.03e-06	4.83e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PTEN—lung cancer	5.01e-06	4.82e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	5.01e-06	4.81e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL6—lung cancer	5e-06	4.8e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—AKT1—lung cancer	5e-06	4.8e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—AKT1—lung cancer	4.99e-06	4.79e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—EP300—lung cancer	4.98e-06	4.79e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ABCB1—lung cancer	4.97e-06	4.78e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CASP3—lung cancer	4.96e-06	4.77e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL2—lung cancer	4.95e-06	4.76e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL6—lung cancer	4.93e-06	4.73e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	4.89e-06	4.7e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—TYMS—lung cancer	4.88e-06	4.69e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EP300—lung cancer	4.88e-06	4.69e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EP300—lung cancer	4.87e-06	4.68e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTM1—lung cancer	4.83e-06	4.64e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCND1—lung cancer	4.83e-06	4.64e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CD—lung cancer	4.82e-06	4.63e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—JUN—lung cancer	4.82e-06	4.63e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EP300—lung cancer	4.78e-06	4.59e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ALB—lung cancer	4.76e-06	4.57e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SRC—lung cancer	4.75e-06	4.56e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SRC—lung cancer	4.74e-06	4.55e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MMP9—lung cancer	4.69e-06	4.5e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	4.67e-06	4.49e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PTEN—lung cancer	4.66e-06	4.48e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SRC—lung cancer	4.65e-06	4.47e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—VEGFA—lung cancer	4.63e-06	4.44e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—VEGFA—lung cancer	4.62e-06	4.43e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—AKT1—lung cancer	4.61e-06	4.43e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—STAT3—lung cancer	4.58e-06	4.4e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP1A1—lung cancer	4.58e-06	4.4e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—STAT3—lung cancer	4.57e-06	4.39e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NRAS—lung cancer	4.57e-06	4.39e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NRAS—lung cancer	4.56e-06	4.38e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	4.55e-06	4.37e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ERCC2—lung cancer	4.54e-06	4.36e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	4.53e-06	4.35e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—STAT3—lung cancer	4.48e-06	4.31e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NRAS—lung cancer	4.47e-06	4.3e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CB—lung cancer	4.46e-06	4.28e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EP300—lung cancer	4.44e-06	4.27e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTGS2—lung cancer	4.42e-06	4.25e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK3—lung cancer	4.38e-06	4.2e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK3—lung cancer	4.37e-06	4.2e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SRC—lung cancer	4.32e-06	4.15e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	4.28e-06	4.12e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MYC—lung cancer	4.26e-06	4.09e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MYC—lung cancer	4.25e-06	4.08e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	4.21e-06	4.04e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CB—lung cancer	4.2e-06	4.04e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MYC—lung cancer	4.17e-06	4e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—STAT3—lung cancer	4.17e-06	4e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTGS2—lung cancer	4.16e-06	4e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EGFR—lung cancer	4.16e-06	4e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NRAS—lung cancer	4.16e-06	3.99e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EGFR—lung cancer	4.15e-06	3.99e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EGFR—lung cancer	4.08e-06	3.92e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	3.98e-06	3.83e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—KRAS—lung cancer	3.93e-06	3.78e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CA—lung cancer	3.93e-06	3.78e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOA1—lung cancer	3.93e-06	3.77e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—KRAS—lung cancer	3.92e-06	3.77e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MYC—lung cancer	3.87e-06	3.72e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTEN—lung cancer	3.85e-06	3.7e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—KRAS—lung cancer	3.85e-06	3.7e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGFR—lung cancer	3.79e-06	3.64e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CA—lung cancer	3.69e-06	3.54e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—EP300—lung cancer	3.67e-06	3.53e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTEN—lung cancer	3.63e-06	3.49e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	3.61e-06	3.47e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CA—lung cancer	3.6e-06	3.46e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CG—lung cancer	3.59e-06	3.44e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—KRAS—lung cancer	3.58e-06	3.44e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	3.54e-06	3.4e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TP53—lung cancer	3.5e-06	3.36e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TP53—lung cancer	3.49e-06	3.35e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—EP300—lung cancer	3.46e-06	3.33e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TP53—lung cancer	3.42e-06	3.29e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—POMC—lung cancer	3.41e-06	3.28e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—HRAS—lung cancer	3.34e-06	3.21e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HRAS—lung cancer	3.34e-06	3.2e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CREBBP—lung cancer	3.32e-06	3.19e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	3.29e-06	3.16e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HRAS—lung cancer	3.27e-06	3.14e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—AKT1—lung cancer	3.21e-06	3.09e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6—lung cancer	3.2e-06	3.07e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6—lung cancer	3.19e-06	3.07e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TP53—lung cancer	3.18e-06	3.06e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CD—lung cancer	3.15e-06	3.03e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6—lung cancer	3.13e-06	3.01e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALB—lung cancer	3.11e-06	2.99e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HRAS—lung cancer	3.04e-06	2.92e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—AKT1—lung cancer	3.01e-06	2.89e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—AKT1—lung cancer	2.95e-06	2.84e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—AKT1—lung cancer	2.94e-06	2.83e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6—lung cancer	2.91e-06	2.8e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AKT1—lung cancer	2.89e-06	2.78e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.75e-06	2.64e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTGS2—lung cancer	2.72e-06	2.62e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CA—lung cancer	2.72e-06	2.61e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AKT1—lung cancer	2.69e-06	2.58e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CA—lung cancer	2.56e-06	2.46e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTEN—lung cancer	2.37e-06	2.28e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—EP300—lung cancer	2.26e-06	2.18e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—AKT1—lung cancer	2.22e-06	2.13e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—AKT1—lung cancer	2.09e-06	2.01e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.67e-06	1.61e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—AKT1—lung cancer	1.37e-06	1.31e-05	CbGpPWpGaD
